Rolf Kramer
Impact in
- Epidemiology top 5%
- Respiratory viral infections research
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria
Papers in
- Epidemiology 39
- Respiratory viral infections research 37
- Influenza Virus Research Studies 2
-
- COVID-19 epidemiological studies 2
- Co-authors
- Wolf‐Rainer Abraham (3 shared papers)Bruno Lina (4 shared papers)Annette Sauer‐Heilborn (3 shared papers)Carlos A. Guzmán (3 shared papers)Manfred G. Höfle (3 shared papers)Tobias Welte (3 shared papers)Thulani Peter Makhalanyane (1 shared paper)Marc W. Van Goethem (1 shared paper)
- Journals
- The Journal of Infectious Diseases (8 papers)Influenza and Other Respiratory Viruses (6 papers)Eurosurveillance (5 papers)The Pediatric Infectious Disease Journal (3 papers)Vaccine (2 papers)
- Partner nations
- FranceNetherlandsGermany
In The Last Decade
Rolf Kramer
50 papers receiving 1.1k citations
Rolf Kramer's Hit Papers
Peers
Comparison fields: 5 of 76
- Epidemiology 549
- Molecular Medicine 73
- Hepatology 46
- Ecology 104
- Pharmacology 68
Countries citing papers authored by Rolf Kramer
This map shows the geographic impact of Rolf Kramer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rolf Kramer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rolf Kramer more than expected).
Fields of papers citing papers by Rolf Kramer
This network shows the impact of papers produced by Rolf Kramer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rolf Kramer. The network helps show where Rolf Kramer may publish in the future.
Co-authors
The 25 scholars most cited alongside Rolf Kramer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study Hit paper breakdown → | 2024 | 186 |
| 2 | 2011 | 166 | |
| 3 | 2017 | 110 | |
| 4 | 2015 | 65 | |
| 5 | 2018 | 58 | |
| 6 | 2018 | 56 | |
| 7 | 2019 | 56 | |
| 8 | 2018 | 39 | |
| 9 | 2024 | 33 | |
| 10 | 2014 | 32 | |
| 11 | 2015 | 22 | |
| 12 | 2024 | 22 | |
| 13 | 2020 | 21 | |
| 14 | 2023 | 19 | |
| 15 | 2025 | 19 | |
| 16 | 2023 | 16 | |
| 17 | 2024 | 16 | |
| 18 | 2022 | 15 | |
| 19 | 2023 | 15 | |
| 20 | 2019 | 13 |
About Rolf Kramer
Rolf Kramer is a scholar working on Epidemiology, Modeling and Simulation, Molecular Medicine, Infectious Diseases and Oncology, having authored 53 papers that have together received 1.2k indexed citations. Recurring topics across this work include Respiratory viral infections research (37 papers), Influenza Virus Research Studies (2 papers), Cystic Fibrosis Research Advances (2 papers), COVID-19 and healthcare impacts (2 papers), COVID-19 epidemiological studies (2 papers), Antibiotic Resistance in Bacteria (2 papers), Antifungal resistance and susceptibility (1 paper) and Bacteriophages and microbial interactions (1 paper). The work is most often cited by research in Epidemiology (549 citations), Molecular Medicine (73 citations), Hepatology (46 citations), Ecology (104 citations) and Pharmacology (68 citations). Rolf Kramer has collaborated with scholars based in France, Netherlands and Germany. Frequent co-authors include Wolf‐Rainer Abraham, Bruno Lina, Annette Sauer‐Heilborn, Carlos A. Guzmán, Manfred G. Höfle, Tobias Welte, Thulani Peter Makhalanyane, Marc W. Van Goethem, Don Arthur Cowan and Ian D. Hogg. Their work appears in journals such as The Journal of Infectious Diseases, Influenza and Other Respiratory Viruses, Eurosurveillance, The Pediatric Infectious Disease Journal and Vaccine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.